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in calf muscles of individuals with diabetes with
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Objective: To assess alterations in the regional perfusion and oxygenation of the calf muscles in individuals with diabetes.
Methods: Age-matched individuals with (n [ 5) and without diabetes (n [ 6) were investigated. Skeletal muscle perfu-
sion, oxygen extraction fraction, and oxygen consumption rate were measured by newly developed noncontrast magnetic
resonance imaging (MRI) techniques. The subjects lay supine on the MRI table with their foot ﬁrmly strapped to
a custom-built isometric exercise device. The measurements were performed at rest and during an isometric plantar
ﬂexion muscle contraction.
Results: Individuals without diabetes had up to a 10-fold increase in muscle perfusion, 25% elevation in muscle oxygen
extraction fraction, and a 12-fold increase in oxygen consumption rate in the calf during the plantar ﬂexion isometric
contraction. In patients with diabetes, the increases in these parameters were only up to sixfold, 2%, and sixfold,
respectively. Exercise oxygen consumption rate was inversely associated with blood HbA1c levels (r2 [ .91).
Conclusions: This is the ﬁrst study to quantify regional skeletal muscle oxygenation in patients with diabetes using
noncontrast MRI and warrants additional study. Attenuation of perfusion and oxygenation during exercise may have
implications for understanding diabetic complications in the lower extremities. (J Vasc Surg 2014;59:419-26.)Complications affecting the lower extremity, such as
ulceration, neuropathy, and structural changes of the
foot, are a major cause of morbidity associated with dia-
betes mellitus (DM). Circulatory compromise to the
extremity is known to have a major impact on the develop-
ment of these complications.1 However, the effects of DM
on the circulatory system and the impact of those changes
on the delivery of blood to the tissues of the leg are only
crudely understood. It is well recognized that individuals
with DM are prone to relatively distinct clinical manifesta-
tions of dysfunction of both the macrocirculation and
microcirculation. TheseDM-related changes include calciﬁc
atherosclerosis, particularly of the tibial vessels, reduced
capillary size, altered endothelial function, and thicken-
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://dx.doi.org/10.1016/j.jvs.2013.07.115underlying mechanisms, and in particular, the relationship
between the microvascular disease, macrovascular disease,
and the lower extremity complications have not been well
deﬁned. In part, this has not been explored because of the
lack of reproducible quantiﬁable measures of end-organ
perfusion.
Traditionally, the macrocirculation was assessed by
ankle/brachial index, contrast imaging of the vessels, and
ultrasound duplex.3 These assessments are reproducible
and clinically valuable to evaluate and plan treatment for
stenotic/occlusive disease in the larger vessels. Unfortu-
nately, there does not yet exist a similar clinically valuable
technique to assess the microcirculatory changes that may
also have an important effect on the functional perfusion
of the tissues. A number of noninvasive imaging techniques
have been used to assess local skin perfusion or oxygena-
tion (<3 mm depth), such as capillaroscopy,4,5 thermog-
raphy,6 laser Doppler ﬂowmetry,7 laser Doppler
imaging,8 transcutaneous O2 tension,
9 or orthogonal
polarization spectral imaging.10 These imaging techniques,
however, have relatively low spatial resolution, reliability,
reproducibility, and sensitivity, and none has been widely
adopted into clinical practice. The techniques also are
limited to the skin, and thus do not provide information
on regional muscle perfusion or oxygenation, which may
have an impact on the function of the leg and foot.11
Another technique that can assess peripheral microcircula-
tion is contrast-enhanced ultrasound.12,13 However, it
usually provides semiquantitative measurements without
any information about oxygen utility.
Magnetic resonance imaging (MRI) is a noninvasive
imaging modality that provides excellent soft tissue419
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of anatomy, perfusion, and metabolism in skeletal
muscle.14-18 We anticipate that delineation of the lower
extremity perfusion with this modality could lead to impor-
tant insights into the impact of microvascular changes on
the development of DM-related complications in the
limb. Recently, we have developed a new MRI method
to assess skeletal muscle perfusion, also called skeletal
muscle blood ﬂow (SMBF), and oxygen extraction fraction
(SMOEF). The latter is deﬁned as ([O2]artery[O2]vein)/
[O2]artery and represents the relationship between skeletal
muscle oxygen supply and demand. A lower number repre-
sents lower oxygen extraction by the muscle. The feasibility
of the measurement was demonstrated in healthy young
volunteers.19 In this pilot study, feasibility for the assess-
ment of regional muscle perfusion and oxygenation is
demonstrated in DM patients without known macrovascu-
lar disease, in comparison with age-matched healthy volun-
teers. It is hypothesized that the microvascular changes
related to DM result in impairment of the regional skeletal
muscle perfusion and oxygenation.
METHODS
Patients. Six healthy volunteers (age, 706 3 years old;
body mass index, 32.3 6 8.9 kg/m2) and ﬁve nonsmoking
DM patients (age, 66 6 5 years old; body mass index,
37.9 6 7.1 kg/m2; HbA1c, 7.7% 6 2.0%; type 1, n ¼ 1;
type 2, n ¼ 4) were recruited for the measurement of
perfusion and oxygenation in the calf muscle. The healthy
volunteers were nonsmokers, free of cardiovascular, meta-
bolic, and musculoskeletal diseases, and did not have
a history of DM or peripheral neuropathy. These volunteers
were screened by a questionnaire regarding their history and
symptoms. For the DM patients, the mean duration of DM
was 7.46 7.3 years. Three DM patients (type 1, n¼ 1; type
2, n ¼ 2) had peripheral neuropathy, determined by the
inability to sense the 5.07 Semmes-Weinstein mono-
ﬁlament and no vibration perception<25 volts measured at
the plantar great toe. None of them had a history or current
plantar ulcer. All of the DM subjects had a history of
cardiovascular disease (4 with hypertension, 2 with cardiac
artery bypass graft, and 2 with a myocardial infarction), but
none of the subjects had a documented history of peripheral
vascular disease. Activity level and exercise capacity were not
measured in these groups of subjects but based on previous
study of a similar subject population; we expect that the DM
subjects had lower physical performance compared with the
healthy controls.29 The local human study committee
approved this study, and signed consent forms were
received from all volunteers prior to the imaging sessions.
Data collection. Subjects were instructed to not
consume alcohol or perform any moderate to heavy exer-
cise 24 hours prior to the imaging session. Each subject
was positioned supine on the MRI table with his or her
right foot ﬁrmly strapped to a pedal of a custom-built
isometric exercise device.19 The resistance of the pedal to
depression was adjusted on an individual basis (mean
resistance force, 67.7 6 6.5 N) to allow the subject tocompletely depress the pedal for the duration of the scan
(up to 6 minutes).
Prior to the exercise study, a phase-array cardiac coil
was placed between the knee and the heel to cover the
lower legs. A three-dimensional noncontrast MR angiog-
raphy was then acquired,20 which was used to detect any
hemodynamically signiﬁcant stenosis ($50%) in large
peripheral vessels (anterior tibial artery, posterior tibial
artery, and peroneal artery). This approach was established
recently with superior sensitivity and speciﬁcity.21 The
MRI perfusion and oxygenation measurements were subse-
quently performed at rest and during a sustained isometric
contraction of the plantar ﬂexor muscles, which included
the gastrocnemius and soleus muscles. Speciﬁcally, each
measurement started at 2 minutes after the start of contrac-
tion, resulting in a total contraction time of approximately
3 minutes for a perfusion measurement and 6 minutes for
an oxygenation measurement (see Imaging Methods
section). There were few reports about the steady-state
time for muscle perfusion and oxygenation during an
isometric contraction. It was estimated that this steady-
state time for leg muscle perfusion can be reached
after 1 to 2 minutes of muscle contraction.22 There was
a 5-minute rest interval after exercise measurements.
Imaging methods. All images were acquired on
a Siemens 3T Trio whole-body scanner (Siemens Health-
care, Malvern, Pa). A study using the methods here was
reported recently in healthy young human subjects.31 To
measure SMBF, an arterial spin-labeling method was
adapted for skeletal muscle imaging.23 The two-
dimensional arterial spin-labeling sequence parameters
included: gradient-echo acquisition; repetition time (TR)/
echo time (TE), 2.8/1.2 ms; 10 T1-weighted images for
each T1 measurement; ﬂip angle, 5; ﬁeld of view (FOV),
160  112 mm2; data acquisition matrix, 128  90; data
average, 3; acquisition time, 50 seconds. A single transverse
slice was scanned in the middle of the calf muscle.
Skeletal muscle oxygenation is represented by both
SMOEF and the oxygen consumption rate (SMVO2).
The latter can be determined using Fick’s law: SMVO2 ¼
[O2]a  SMOEF  SMBF. The constant [O2]a is deﬁned
as the total oxygen content of arterial blood, and a value of
8.61 mmol  mL1 was used for this pilot study.24 The
SMVO2 provides an accurate measure of total oxygen
metabolism in skeletal muscle. The MRI method for
SMOEF measurement is based on a method developed
for the brain, which relies on the magnetic susceptibility
effect of intravascular deoxyhemoglobin.25,26 A multi-
slice two-dimensional triple-echo asymmetric spin-echo
sequence was employed to acquire source images for
SMOEF measurements.36 The imaging parameters are:
TR, 4 sec; TE1/TE2/TE3, 44/62/80 ms; FOV, 160 
140 mm2; data acquisition matrix size, 64  56 and inter-
polated to 128  112; single slice, slice thickness, 8 mm;
total acquisition time, 3 minutes 48 seconds.
The three-dimensional noncontrast angiography uses
images acquired during systole and diastole to remove
the venous signals so that arteries can be clearly depicted.
Fig 1. Examples of skeletal muscle blood ﬂow (SMBF) maps, at rest and during isometric contraction, from a healthy
volunteer (A and B) and an age-matched diabetes mellitus (DM) patient (C and D). The yellow and red regions of
interest in the SMBF map of (A) indicate the soleus and gastrocnemius muscle regions, respectively. Reduced SMBF in
DM from the contraction can be easily seen in the subtracted map (D), compared with the map of a healthy volunteer
in (B). Color bar range, 0 to 150 mL/100 g/min.
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true fast imaging with steady-state precession TR/TE,
3.8 ms/1.63 ms; ﬂip angle, 500; segmentation number,
40; generalized autocalibrating partially parallel acquisi-
tions acceleration factor, 2; FOV, 390  390; matrix,
432  432; 80 slices; isotropic resolution, 0.9  0.9 
0.9 mm3; total acquisition, 6 to 7 minutes.
Image analysis. SMOEF and SMBFmaps were created
using a custom software written in Matlab (MathWorks,
Natick, Mass).19,24 Because the plantar ﬂexion isometric
contraction primarily affects the soleus and gastrocnemius
muscles, region-of-interest measurements were performed
in these two muscle regions (Fig 1).19 In addition, the two
muscle regions were positioned closest to the surface coil,
resulting in the highest SNR enhancing the accuracy of our
measurement. The deep plantar ﬂexion compartment
muscles (ie, tibialis posterior, ﬂexor halluces longus, and
ﬂexor digitorum longus) were excluded from analysis due to
relatively lower signal-to-noise ratio. SMVO2 data were
then subsequently calculated. The hemodynamic reserves
(ratio of exercise value to the resting value) from three
parameters, SMBF, SMOEF, and SMVO2, were calculated
to gauge the exercise performance.
Statistical analysis. Data are reported as mean 6 stan-
dard deviation. The comparison between the healthy and
DM groups was made using independent two-sided
Student t-tests with two samples and equal variance. The
comparison between rest and isometric exercise was made
using paired, two-sided Student t-tests. The relationshipbetween quantitative MRI parameters and HbA1c was
determined using an empirical exponential curve. Signiﬁ-
cance for all statistical tests was deﬁned as P < .05.
RESULTS
All subjects completed the imaging protocol without
difﬁculty. No apparent motion artifacts were noticed in
any MR source images. None of the subjects had signiﬁ-
cant peripheral arterial stenosis as assessed from the non-
contrast three-dimensional MR angiography.
Table I lists the average values of SMBF, SMOEF, and
SMVO2 for the gastrocnemius and soleus muscles. In
healthy volunteers, the resting values of SMBF, SMOEF,
and SMVO2 in the soleus muscle were 7.3 6 .9 mL/
100 g/min, .36 6 .04, and .49 6 .1 mL/100 g/min,
respectively. These hemodynamic parameters all increased
signiﬁcantly during the isometric exercise to 57.8 6
15.8 mL/100 g/min (P < .001), .43 6 .08 (P < .05),
and 4.64 6 1.4 mL/100 g/min (P < .01), respectively.
The gastrocnemius muscle in healthy volunteers had similar
resting and exercise values for these parameters.
In the soleus muscle of the DM group (Table I, A),
resting SMBF was signiﬁcantly lower than that in the
healthy group (5.8 6 .8 mL/100 g/min vs 7.3 6
.9 mL/100 g/min in healthy; P ¼ .03), but resting
SMOEF and SMVO2 were not signiﬁcantly different
from those found in the healthy volunteers. The exercise
SMBF and SMVO2 in the DM group were signiﬁcantly
lower than those in the healthy group (SMBF, 34.7 6
Table I. A, Hemodynamics measured by noncontrast magnetic resonance imaging (MRI) in soleus muscle
Subjects
SMBF (mL/100 g/min) SMOEF SMVO2 (mL/100 g/min)
Rest Contraction Rest Contraction Rest Contraction
Healthy (6) 7.3 6 .9 57.8 6 12.1a .36 6 .04 .43 6 .09a .49 6 .10 4.62 6 1.41a
DM (5) 5.8 6 .8b 34.7 6 3.1a,b .48 6 .15 .43 6 .10 .53 6 .21 2.76 6 .72a,b
DM,Diabetes mellitus; SMBF, skeletal muscle blood ﬂow; SMOEF, skeletal muscle oxygen extraction fraction; SMVO2, skeletal muscle oxygen consumption rate.
aP < .05, contraction vs rest.
bP < .05, DM vs healthy.
Table I. B, Hemodynamics measured by noncontrast magnetic resonance imaging (MRI) in gastrocnemius muscle
Subjects
SMBF (mL/100 g/min) SMOEF SMVO2 (mL/100 g/min)
Rest Contraction Rest Contraction Rest Contraction
Healthy (6) 6.0 6 .8 57.4 6 11.6a .41 6 .05 .52 6 .09a .45 6 .07 5.45 6 1.50a
DM (5) 6.4 6 .5 33.2 6 12.5a,b .46 6 .20 .46 6 .16 .54 6 .20 2.98 6 1.89a,b
DM,Diabetes mellitus; SMBF, skeletal muscle blood ﬂow; SMOEF, skeletal muscle oxygen extraction fraction; SMVO2, skeletal muscle oxygen consumption rate.
aP < .05, contraction vs rest.
bP < .05, DM vs healthy.
Table II. A, Hemodynamic reserves measured by
noncontrast magnetic resonance imaging (MRI) in soleus
muscle
Subjects SMBF reserve SMOEF reserve SMVO2 reserve
Healthy (6) 8.03 6 1.71 1.19 6 .18 9.59 6 2.86
DM (5) 6.05 6 1.12a .92 6 .22a 5.72 6 2.34b
DM, Diabetes mellitus; SMBF, skeletal muscle blood ﬂow; SMOEF, skeletal
muscle oxygen extraction fraction; SMVO2, skeletal muscle oxygen
consumption rate.
aP ¼ .05, DM vs healthy.
bP < .05, DM vs healthy.
Table II. B, Hemodynamic reserves measured by
noncontrast magnetic resonance imaging (MRI) in
gastrocnemius muscle
Subjects SMBF reserve SMOEF reserve SMVO2 reserve
Healthy (6) 9.76 6 2.77 1.27 6 .19 12.56 6 4.95
DM (5) 5.54 6 2.54b 1.02 6 .07b 5.66 6 2.59b
DM, Diabetes mellitus; SMBF, skeletal muscle blood ﬂow; SMOEF, skeletal
muscle oxygen extraction fraction; SMVO2, skeletal muscle oxygen
consumption rate.
aP ¼ .05, DM vs healthy.
bP < .05, DM vs healthy.
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healthy; P ¼ .003; SMVO2, 2.76 6 .72 mL/100 g/min
vs 4.62 6 1.41 mL/100 g/min in healthy; P ¼ .02).
However, exercise SMOEF in the DM group was not
signiﬁcantly different from that in the healthy group.
In the gastrocnemius muscle of the DM group
(Table I, B), all resting SMBF, SMOEF, and SMVO2 were
not signiﬁcantly different from those found in the healthy
group. The exercise SMBF and SMVO2 in the DM group
were signiﬁcantly lower than those in the healthy group
(SMBF, 33.2 6 12.5 mL/100 g/min vs 57.4 6
11.6 mL/100 g/min in healthy; P < .01; SMVO2,
2.98 6 1.89 mL/100 g/min vs 5.45 6 1.50 mL/100 g/
min in healthy; P¼ .04). Like in the soleus muscle, the exer-
cise SMOEF in the gastrocnemius muscle of the DM group
was the same as resting SMOEF, but not signiﬁcantly
different from the exercise SMOEF in the healthy group.
Table II, A and B show the reserves of each hemody-
namic parameter. There were signiﬁcant decreases in
SMVO2 reserve in the soleus and gastrocnemius muscles
in the DM group compared with the healthy group (soleus,
5.72 6 2.34 vs 9.59 6 2.86 in healthy; P ¼ .04; gastroc-
nemius, 5.66 6 2.59 vs 12.56 6 4.95 in healthy; P ¼
.02). It is noticed, however, that there are regional differ-
ences between soleus and gastrocnemius muscles in terms
of SMBF and SMOEF reserves. Both SMBF and SMOEF
reserves in the gastrocnemius region of the DM group
were signiﬁcantly lower than those in the healthy group
(SMBF, 5.54 6 2.54 in DM vs 9.76 6 2.77 in healthy;
P ¼ .02; SMOEF, 1.02 6 .07 in DM vs 1.27 6 .19 in
healthy; P ¼ .03), but not for the soleus region. Figs 1
and 2 show maps of SMBF and SMOEF from one healthy
and one type 2 DM patient with an HbA1c level of 6.4,
respectively.Fig 3 shows the relationships between HbA1c and
exercise SMVO2 and SMBF in the DM group. With
increased HbA1c, exercise SMVO2 decreased exponen-
tially with a correlation coefﬁcient r2 of 0.91 for both
muscle regions. However, the gastrocnemius muscle
appeared to decay more quickly than the soleus muscle
with a decay constant of .316 vs .135. It is noted that
Fig 2. Skeletal muscle oxygen extraction fraction (SMOEF) maps, at rest and during isometric contraction, from the
same subjects in Fig 1: a healthy volunteer (A) and an age-matched diabetes mellitus (DM) patient (B). Elevated
SMOEF in a healthy volunteer during the contraction can be observed. In contrast, the SMOEF map of contraction in
DM patient shows similar intensity as the map of rest. Color bar range, 0.1 to 0.8.
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cluded in this pilot study only to demonstrate the trend
of the data. In a similar fashion, exercise SMBF decreased
appreciably in the gastrocnemius muscle, but it was un-
changed with increasing HbA1c level in the soleus muscle.
There is no association between HbA1c and exercise
SMOEF or any resting hemodynamic parameters.
DISCUSSION
The development of complications of the legs and feet
in patients with DM is understood to be the result of
a number of factors that are likely interrelated. Some of
the most prominent features include neuropathy, immune
dysfunction, and circulatory compromise. This is the ﬁrst
study to quantify regional skeletal muscle oxygenation in
patients with DM using a noncontrast MRI approach.
During an isometric exercise, signiﬁcant increases in
SMBF, SMOEF, and SMVO2 were observed in all healthy
volunteers, both in the soleus and gastrocnemius muscles.
In contrast, patients with DM had attenuated elevations
of these parameters, reﬂected by 20% to 55% reductions
in the reserves (Table II, A and B). Furthermore, exercise
SMBF and SMVO2 in the gastrocnemius muscle decreasedwith elevated HbA1c levels in the DM group. Similar
reduction was also observed in the soleus muscle, but to
a lesser degree.
Compared with an eight- to 10-fold increase in exercise
SMBF in the healthy group, patients with DM showed only
a ﬁve- to sixfold increase. There is compiling evidence to
suggest limb arterial blood ﬂow is impaired in patients
with DM.27,28 Lalande et al found that reduced exercise
femoral arterial blood ﬂow in patients with type 2 diabetes
is caused by impaired vascular function and is independent
of cardiac output.29 Reduced perfusion reserve was clearly
observed in patients with DM without peripheral arterial
disease, using 99mTc-MIBI.30 Our SMBF data are in
general agreement with these ﬁndings. Furthermore, we
have observed that the gastrocnemius muscle appeared to
have greater reduction in SMBF reserve than the soleus
muscle (43% vs 25% reduction) in patients with DM. There
are two possible explanations for the differences measured
in the gastrocnemius compared with the soleus. The ﬁrst is
that previous research has reported that the gastrocnemius
shows two times the fat inﬁltration compared with the
soleus muscle in persons with diabetes and peripheral
neuropathy.31 The second is that the gastrocnemius is
Fig 3. Relationships of exercise skeletal muscle blood ﬂow (SMBF) and skeletal muscle oxygen consumption rate
(SMVO2) with HbA1c in patients with diabetes mellitus (DM). The fast-twitch gastrocnemius muscle shows more
decreased values with increased HbA1c than the slow-twitch soleus muscle during the isometric contraction. The
exercise SMBF is less sensitive to the changes in HbA1c than the exercise SMVO2. The empirical exponential ﬁtting
curves are used to show the trend of the data.
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muscle, and there is a lower capillary density in fast-
twitch muscle compared with slow-twitch muscle. How-
ever, the underlying mechanisms of vascular or muscle
changes in DM is unknown at this stage.
For muscle oxygenation, there were signiﬁcant in-
creases in SMOEF (20% to 27%; P < .05) and SMVO2
(nine- to 10-fold; P < .01) from rest to exercise in the
healthy group. In patients with DM, exercise-induced
changes in SMOEF (no signiﬁcant change), and SMVO2
(ﬁve- to sixfold; P < .05) were signiﬁcantly attenuated.
This is in accordance with evidence that found diabetes
results in slowed oxygen uptake kinetics and reduced exer-
cise capacity.32,33 In addition, there were some noticeable
differences observed between the gastrocnemius and soleus
muscles. In the healthy group, the SMOEF and SMVO2
appeared to have a greater increase from rest to exercise
in gastrocnemius muscle than soleus muscle. This is consis-
tent with the ﬁnding in rats where a greater O2 extraction
fraction was demonstrated in muscle comprised of fast-
twitch ﬁber compared with their slow-twitch counterparts
during a twitch contraction.34 In the DM group, such
regional differences in SMOEF and SMVO2 remained
similar to the healthy group.
It is noted that resting SMBF of soleus muscle in the DM
group vs the healthy group was signiﬁcantly reduced.
However, there was no signiﬁcant difference in resting
SMBF of gastrocnemius muscle between DM and healthy
groups. This appears to be consistent with a recent report
that a resting MRI relaxation time T2* (effective transverse
relaxation time in inhomogeneous magnetic ﬁelds) in the
soleusmuscleofDMpatients is signiﬁcantly reduced (as deox-
yhemoglobin concentration is increased due to less SMBF),
compared with healthy controls.35 Although this observation
is not fully understood, it was explained by the greater reduc-
tion in capillaries in the soleus muscle of DM patients due to
its slow-twitch ﬁbers and oxidative metabolism.33
The reduced exercise SMBF and SMVO2 with in-
creasing HbA1c levels (Fig 2) may indicate hyperglycemia-
induced vasoactive dysfunction.36 Many studies have
suggested that insulin directly acts on the endothelium ofthe vessel wall by stimulation of nitric oxide production,
speciﬁcally augmentation of nitric oxide synthase via the
phosphatidylinositol-3 kinase Akt pathway.37-39 Such
reduced ﬂow response in DM is associated with dysfunc-
tion of the oxygen transport pathway (eg, reduced total
oxygen extraction, oxygen consumption, and submaximal
exercise capacity).40-42 However, all of these studies used
total body VO2 max to represent the total oxygen
consumption. This study conﬁrmed the ﬁndings of reduced
oxygenation in patients with DM and is the ﬁrst one to
demonstrate regional differences in the oxygenation of
different muscle groups. The hemodynamic responses of
the gastrocnemius muscle appear to be affected by the
HbA1c level more than the soleus muscle. This is possibly
due to the disparity of muscle ﬁber type (fast-twitch vs
slow-twitch), capillary density, oxygen metabolism (anaer-
obic vs oxidative metabolism), and/or greater fat inﬁltra-
tion in the gastrocnemius compared with the soleus in
patients with DM.29,30 The exact underlying mechanism
is unknown, and future study needs to isolate each factor
to elucidate the pathway of oxidation dysfunction in
different muscle groups of patients with DM.
We believe that direct evaluation and measurement of
the regional perfusion of the lower extremities holds great
potential to advance the care and management of diabetic
patients. An optimal test of regional perfusion could herald
a number of changes in clinical management including: (1)
provide a more accurate screening prior to invasive arterial
evaluation; (2) direct interventional strategies to improve
perfusion; (3) accelerate the institution of novel interven-
tions such as local angiogenic therapy; and (4) accelerate
deﬁnitive decisions for diabetes foot ulcers when healing
potential appears to be insufﬁcient. In this pilot study,
the DM patients had a variety of cardiovascular diseases.
However, it is unknown whether reduced exercise perfusion
in the DM patients is related to the cardiovascular function
and/or sympathetic activity. In a small study of type 2 DM
patients without cardiovascular disease, reduced skeletal
muscle perfusion was independent of cardiac output during
a submaximal exercise.29 We suspected that both impaired
central cardiovascular function and reduced local blood
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 2 Zheng et al 425ﬂow affect the exercise capacity in the DM patients. This
needs a large scale of clinical study to validate.
There are several limitations in this pilot study. As this
is a technical development study, rather than a hypothesis-
testing study, we had a small number of participants with
both type 1 and 2 diabetes in the DM group. These hemo-
dynamic parameters may be different between type 1 and
type 2 patients. Although the subjects had no clinical mani-
festation or history of peripheral vascular disease, complete
vascular assessment and exercise capacity testing were not
conducted. A large-scale study with complete vascular
and exercise capacity testing will be needed to evaluate
these important factors. In addition, it was noticed that
one DM patient with a duration of DM of 20 years had
the lowest exercise SMOEF and SMVO2, but his exercise
SMBF was comparable with other DM patients. His
HbA1c was also the highest (10.1). Again, due to the small
number of patients, no conclusion can be drawn in this
pilot study regarding the role of duration of DM on the
skeletal muscle microcirculation. Another limitation of
this study is the inability to evaluate the anterior or lateral
muscle compartments due to the low signal intensity
observed using our custom-made surface coil. This
problem could be partially solved using a larger surface
coil that is under development in our laboratory. Finally,
although resistance to plantar ﬂexion was individualized
to allow successful task completion, we did not attempt
to measure each individual’s maximal voluntary contraction
and standardize the resistance. Nevertheless, the standard
deviation of the resistance pressure was small (6.5 N), indi-
cating similar physical resistance among DM patients and
healthy volunteers. The signiﬁcant attenuation in our exer-
cise data in DM patients indicated our conclusions about
this group of patients should remain valid.
CONCLUSIONS
In summary, skeletal muscle perfusion and oxygenation
can be quantiﬁed in healthy and diabetic subjects. Isometric
muscle contraction induced signiﬁcant increases in both
perfusion and oxygenation in healthy subjects, but such
increases were markedly attenuated in patients with DM.
This may have implications for early detection of compro-
mised hemodynamics in the lower extremities of patients
with DM. The exercise oxygen consumption rate appears
to be associated with blood serum HbA1c levels. Heteroge-
neity of hemodynamic responses in gastrocnemius and soleus
musclesmay reﬂect differences in themuscle ﬁber type, capil-
lary volume, and oxidation. The technical advancement
described in this pilot studymay provide a useful noninvasive
tool for understanding of the mechanism of hemodynamic
response to stress in skeletal muscle of patients with DM.
It also may help guide therapeutic strategies to target local
angiogenic factors so that the incidence of abnormal cardio-
vascular outcome can be reduced and even avoided.
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